Interestingly, in KC, the expression of Pparg and its cofactor Ppargc1b was increased, whereas in Mo-Mφ, it was the PPARδ isoform which was upregulated in the context of NASH-HCC. The gene discussed is PPARGC1B; the disease is metabolic dysfunction-associated steatohepatitis.